Literature DB >> 34355125

Splicing mutation in TAZ gene leading to exon skipping and Barth syndrome.

Larysa Sivitskaya1, Nina Danilenko1, Iryna Motuk2, Nikolai Zhelev3,4.   

Abstract

Barth syndrome is a monogenic X-linked disorder characterized by cardiomyopathy, skeletal myopathy and neutropenia. It is caused by deficiency of cardiolipin and associated with mutations in the tafazzin gene (TAZ). A 3 years old boy with dilated cardiomyopathy, neutropenia and growth retardation was investigated. Genetic screening found a new variant in the junction of intron 2 and exon 3 of the TAZ gene - c.239-1_239delinsTT. Functional analysis of the variant revealed the aberrant splicing of exon 3 leading to its complete excision from mature mRNA and frameshift at the beginning of tafazzin. Variant c.239-1_239delinsTT can be classified as pathogenic based on splicing alteration and typical clinical phenotype observed in TAZ mutation carriers. ©2021 Gaetano Conte Academy - Mediterranean Society of Myology, Naples, Italy.

Entities:  

Keywords:  Barth syndrome; TAZ; aberrant splicing; dilated cardiomyopathy; exon skipping

Mesh:

Substances:

Year:  2021        PMID: 34355125      PMCID: PMC8290511          DOI: 10.36185/2532-1900-047

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  12 in total

1.  Defining functional classes of Barth syndrome mutation in humans.

Authors:  Ya-Wen Lu; Laura Galbraith; Jenny D Herndon; Ya-Lin Lu; Mia Pras-Raves; Martin Vervaart; Antoine Van Kampen; Angela Luyf; Carla M Koehler; J Michael McCaffery; Eyal Gottlieb; Frederic M Vaz; Steven M Claypool
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

2.  Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.

Authors:  Diti Ronvelia; Jaclyn Greenwood; Julia Platt; Simin Hakim; Michael V Zaragoza
Journal:  Mol Genet Metab       Date:  2012-09-18       Impact factor: 4.797

3.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

4.  The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study.

Authors:  Amy E Roberts; Connie Nixon; Colin G Steward; Kimberly Gauvreau; Melissa Maisenbacher; Matthew Fletcher; Judith Geva; Barry J Byrne; Carolyn T Spencer
Journal:  Am J Med Genet A       Date:  2012-10-08       Impact factor: 2.802

5.  Seven functional classes of Barth syndrome mutation.

Authors:  Kevin Whited; Matthew G Baile; Pamela Currier; Steven M Claypool
Journal:  Hum Mol Genet       Date:  2012-10-24       Impact factor: 6.150

6.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts.

Authors:  P G Barth; C Van den Bogert; P A Bolhuis; H R Scholte; A H van Gennip; R B Schutgens; A G Ketel
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

7.  Barth syndrome: mechanisms and management.

Authors:  Josef Finsterer
Journal:  Appl Clin Genet       Date:  2019-06-05

8.  Cardiomyopathy in a male patient with neutropenia and growth delay.

Authors:  Veronica Folsi; Nunzia Miglietti; Annamaria Lombardi; Sara Boccacci; Tatiana Utyatnikova; Chiara Donati; Livia Squassabia; Laura Gazzola; Ilaria Bosio; Adele Borghi; Veronica Grassi; Lucia D Notarangelo; Alessandro Plebani
Journal:  Ital J Pediatr       Date:  2014-05-12       Impact factor: 2.638

Review 9.  Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.

Authors:  Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2020-10-01       Impact factor: 4.214

10.  A novel X-linked gene, G4.5. is responsible for Barth syndrome.

Authors:  S Bione; P D'Adamo; E Maestrini; A K Gedeon; P A Bolhuis; D Toniolo
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.